ONCase

N/A

Report date: 2025/06/11 10:22:59

Base Information

Drug NameONCase
Drug Alias NameMEG-PEG-rMETase (AntiCancer/Shionogi/Jiangsu)PEGylated methioninasemethioninase (AntiCancer)methionine lyaserMETase +[12] 
ClassificationCell and gene therapy > Gene therapyBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionEnzymes stimulantsApoptosis stimulantsCell cycle inhibitors
TargetsEnzymes
Therapy Area/IndicationsLung NeoplasmsPancreatic NeoplasmsStomach Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesWestern EuropeJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnticancer Inc
China Registration ClassN/A

Develop Information

Active CompaniesShionogi & Co LtdJiangsu Kingsley Pharmaceutical Co Ltd
Inactive CompaniesAnticancer Inc
Active IndicationsNeoplasms
Inactive IndicationsLung NeoplasmsPancreatic NeoplasmsStomach Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksN/A